Receive in-depth updates on the latest in GI and hepatology, endoscopy, and practice management when you attend one or more of the optional Friday courses. Four courses are offered: two half-day courses, the GI Pathophysiology Course and the What’s New in GI Pharmacology Course; and two full-day courses, the Practice Management Summit and the ASGE Endoscopy Course.Register for any two courses and save up to 10%!
Can’t join us in-person in Las Vegas?
Maximize your learning with one of our VIRTUAL All-Access Pass options and save 20%!
ACG All-Access Pass: The ACG All-Access Pass includes virtual-only access to the GI Pathophysiology Course, GI Pharmacology Course, Practice Management Summit, Postgraduate Course + Bonus Sessions (formerly Learning Luncheons), and the Annual Scientific Meeting + Bonus Sessions (formerly Breakfast Sessions). Registrants will also receive online access to the 2021 Self-Assessment Test.
NEW for 2021: ACG All-Access Pass + ASGE Endoscopy Course: The ACG All-Access Pass includes virtual-only access to all of the courses in the ACG All-Access Pass PLUS the ASGE Endoscopy Course.
What’s New in GI Pharmacology Course
Friday, October 22, 2021 | 1:45 pm - 5:20 pm | Mandalay Bay Ballroom F
Course Directors: Brooks D. Cash, MD, FACG, and William D. Chey, MD, FACG
Experts will define and describe the use and management of new pharmacological therapies as well as provide updates on current pharmacological treatment options for a variety of GI disorders during the What’s New in GI Pharmacology Course.
|Friday, October 22, 2021 │ All times are listed in the Pacific Time Zone|
|1:45 pm||Welcome and Introductions
Brooks D. Cash, MD, FACG, and William D. Chey, MD, FACG
|1:50 pm||Update on Treating C. difficile Infection
Jessica R. Allegretti, MD, MPH
Apply principles of recent guideline updates in the management of patients with C. difficile in a variety of clinical scenarios.
|2:10 pm||Present and Future Treatments for Crohn’s Disease
David T. Rubin, MD, FACG
Identify current best practices for Crohn’s disease and assess the promise of emerging therapies.
|2:30 pm||ACG Clinical Practice Guideline on Pharmacotherapy for IBS
Brooks D. Cash, MD, FACG
Develop evidence-based approaches to the evaluation and pharmacologic treatment of patients with irritable bowel syndrome based on critical review of recent guideline updates.
|2:50 pm||Understanding the Different Treatment Options for Hepatitis C
Kimberly A. Brown, MD
Differentiate among HCV therapies and identify optimal care plans based on specific clinical situations.
|3:10 pm||Q & A|
|3:40 pm||Modernizing H. pylori Therapy
William D. Chey, MD, FACG
Assess and compare the differences between H. pylori therapies and decide on optimal initial and salvage approaches in patients with H. pylori infection.
|4:00 pm||Management of Iron Deficiency Anemia
Cynthia W. Ko, MD, MS
Improve the diagnostic evaluation of iron deficiency anemia and apply updated recommendations for its management with a focus on the differing pharmacology of iron replacement therapies.
|4:20 pm||Treatment Options for Recurrent Nausea and Vomiting
Christine Y. Hachem, MD, FACG
Describe the most common etiologies causing recurrent nausea and vomiting and formulate approaches to these symptoms using current diagnostics and therapeutics.
|4:40 pm||Diagnosis and Treatment of Microscopic Colitis
Darrell S. Pardi, MD, MS, FACG
Accurately diagnose microscopic colitis and construct appropriate treatment algorithms based on current and emerging knowledge.
|5:00 pm||Q & A and Course Wrap-Up|
|5:20 pm||What's New in GI Pharmacology Course Adjourns|